Search
Concentra Group Holdings Parent Inc
CONAdd to Watchlist
28.560USD
+0.170+0.60%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.67BMarket Cap
20.60P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Concentra Group Holdings Parent Inc is 8.25, ranking 23 out of 76 in the Healthcare Providers & Services industry. The average price target is 28.50, with a high of 30.00 and a low of 25.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
31.143
Target Price
+9.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Concentra Group Holdings Parent Inc
CON
8
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Concentra Group Holdings Parent Inc's expected revenue for the next quarter?
Concentra Group Holdings Parent Inc's expected revenue is 591.72M.
What is Concentra Group Holdings Parent Inc's price target?
Analysts forecast that Concentra Group Holdings Parent Inc's price target is USD 28.50, with the highest forecast at USD 30.00 and the lowest forecast at USD 25.00.
How have Concentra Group Holdings Parent IncCON's recent earnings per share performed?
The market expectation was USD 0.39, while Concentra Group Holdings Parent IncCON's earnings per share (EPS) for the previous quarter was USD 0.27. EPS for the next quarter is expected at USD 0.42.
What is the analyst rating for Concentra Group Holdings Parent Inc?
Based on the ratings of Concentra Group Holdings Parent Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
